INTUITIVE SURGICAL INC (ISRG)

Nasdaq · SEC-listed source profile

Listing facts

SEC issuer name
INTUITIVE SURGICAL INC
Ticker
ISRG
Exchange
Nasdaq
Instrument family
Not yet reviewed
SEC issuer CIK
0001035267
Listing source refreshed
2026-09-13

SEC listing source

IEX reference history

Recent completed-session IEX reference closes for this current listing. The chart shows raw, unadjusted single-exchange observations rather than a consolidated U.S. market close.

INTUITIVE SURGICAL INC recent IEX single-exchange reference closing-price history22 observations from Aug 20, 2026 to Sep 21, 2026. Values range from 350.22 to 401.73.
Unadjusted IEX reference closes · Aug 20, 2026–Sep 21, 2026 · 22 observations · per share
IEX Historical Data Terms

Screened reference metrics

These percentage measures use the same qualified observation window and normalize only explicitly registered positive split events. They are reference metrics, not total returns or benchmark-relative performance.

Window return
7.31%
Aug 20, 2026–Sep 21, 2026
Range width
14.71%
Screened closing-price range
Latest range position
100%
Position within screened close range
Average close vs. start
-0.29%
Average screened close relative to starting close
About this market data

IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.

Screened reference metrics use K9-qualified IEX reference history and only explicitly registered positive split events. They do not assert complete split history, consolidated U.S. market performance, or canonical adjusted prices.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.

Company Research Map

These reviewed encyclopedia concepts are supported by public-company evidence for this business. Operating-model groups show how the reported concepts fit together without implying that every metric in the broader model is reported by this issuer.

Research coverage

Start with an operating model, then move into the supported concepts and economic bridges below. Coverage counts describe reviewed evidence links for this issuer, not standardized KPI completeness.

Robotic Surgery Platform Economics

17 reviewed concepts

Connect procedure demand, installed-base growth and utilization, system placements and financing mix, and recurring instruments, service, and lease revenue to understand robotic-surgery platform economics.

How these metrics connect

These bridges come from the reviewed operating model. Linked concepts have public-company evidence for this issuer; broader bridge coverage remains explicit when the model contains additional concepts.

Procedure demand and installed-base utilization
5 of 5 reviewed concepts

Annual procedure volume is driven by the system base available through the year and procedures performed per system. Installed-base growth and utilization growth therefore help separate capacity expansion from deeper use, but the point-in-time installed base and annual procedure count do not form an exact accounting identity.

Placements, financing mix, and system revenue timing
6 of 6 reviewed concepts

System placements add customer capacity through sales and multiple lease structures. Operating-lease placement mix changes when revenue is recognized, so placement growth and systems-revenue growth can diverge because of financing mix, product mix, trade-ins, lease buyouts, and pricing.

Recurring installed-base monetization
7 of 7 reviewed concepts

Intuitive defines recurring revenue as instruments and accessories revenue plus service revenue plus operating lease revenue. Procedure activity drives consumable demand, the installed base supports service economics, and leased systems add recurring system revenue, while the recurring-revenue mix shows the combined contribution relative to total company revenue.